search
Back to results

Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis

Primary Purpose

Acute Appendicitis

Status
Unknown status
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
Ertapenem, Levofloxacin and Metronidazole
Endoscopic retrograde appendicitis therapy (ERAT)
Appendectomy
Sponsored by
First Affiliated Hospital Xi'an Jiaotong University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Appendicitis focused on measuring Acute appendicitis, Endoscopic retrograde appendicitis therapy, Endoscopic retrograde appendicography, Endoscopic therapy, Appendectomy, Antibiotic Therapy

Eligibility Criteria

12 Years - 75 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients with Alvarado scores ≥7 (with or without US/CT) diagnosed of uncomplicated acute appendicitis
  • patients with Alvarado scores <7 but US/CT suggested uncomplicated acute appendicitis or could not exclude acute appendicitis.

Exclusion Criteria:

  • perforated appendicitis
  • periappendiceal abscess
  • contraindications for colonoscopy
  • allergy to contrast media or iodine
  • pregnancy
  • unable to cooperate or provide informed consent

Sites / Locations

  • 3201 Hospital of Hanzhong
  • Second Affiliated Hospital of Xi'an Jiaotong University
  • First Affiliated Hospital of Xian Jiaotong University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Active Comparator

Arm Label

Antibiotic therapy group

ERAT group

Appendectomy group

Arm Description

The patients will be treated with intravenous broad-spectrum antibiotics (Ertapenem 1g/d) for 3 days and oral antibiotics (Levofloxacin 500mg once daily and Metronidazole 500mg 3 times per day) for 7 days. If patients in the antibiotic group deteriorate during the hospital stay (suspicious perforation or any symptoms of peritonitis) patients will be operated.

The patients will receive emergent endoscopic retrograde appendicitis therapy (ERAT).

The patients will receive laparoscopic appendectomy according to standard routines.

Outcomes

Primary Outcome Measures

duration of abdominal pain

Secondary Outcome Measures

mean hospital stay
duration of fever
duration of leukocytosis
bed time
rate of complication
rate of recurrence
rate of appendectomy

Full Information

First Posted
April 24, 2016
Last Updated
May 29, 2016
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Collaborators
3201 Hospital in Hanzhong, Second Affiliated Hospital of Xi'an Jiaotong University
search

1. Study Identification

Unique Protocol Identification Number
NCT02789865
Brief Title
Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis
Official Title
Multicenter Prospective Randomized Clinical Trial Comparing Endoscopic Retrograde Appendicitis Therapy (ERAT) vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2016
Overall Recruitment Status
Unknown status
Study Start Date
May 2016 (undefined)
Primary Completion Date
April 2018 (Anticipated)
Study Completion Date
April 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Collaborators
3201 Hospital in Hanzhong, Second Affiliated Hospital of Xi'an Jiaotong University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Endoscopic retrograde appendicitis therapy (ERAT) is a new and minimally invasive method for the diagnosis and treatment of acute appendicitis.After a positive diagnosis of acute appendicitis is established by either colonoscopic direct-vision imaging or fluoroscopic endoscopic retrograde appendicography (ERA) imaging in patients with suspected acute appendicitis, the procedures to relieve the appendiceal lumen obstruction including appendiceal luminal irrigation, appendicolith removal, and stenting for drainage whenever necessary will be carried out. In this multicenter prospective randomized clinical trial, the patients with uncomplicated acute appendicitis will be divided into three groups randomly: ERAT group, antibiotic therapy group and appendectomy group. The primary outcome is duration of abdominal pain. The secondary outcomes include mean hospital stay, mean operative time, duration of fever, duration of leukocytosis, bed time, rate of complication, rate of recurrence and rate of appendectomy during follow-up period of 1 year.
Detailed Description
Intervention The patients with uncomplicated acute appendicitis will be divided into three groups randomly: ERAT group, antibiotic therapy group and appendectomy group. 1) ERAT group: In preparation for ERAT, low-pressure cleansing enemas (500 mL normal saline solution per enema) will be administered for three times before the procedures for bowel preparation. Antibiotic therapy (levofloxacin + metronidazole) will be intravenously administrated to the patients in the perioperative period. The procedures of ERAT will be performed as below: Cannulation of the appendiceal lumen: Colonoscopic examination under direct vision of the whole colon, ileocecal junction and terminal ileum will be performed to exclude other abnormalities first, and focus on the appendiceal orifice and the surrounding mucosa. Colonoscope attached by a transparent cap will be positioned close to the appendiceal orifice. Gerlach's valve will be pushed aside using the transparent cap, a standard catheter loaded with a 0.035-inch guidewire (loop-tip or hydrophilic-tip) will be placed in the appendiceal orifice. The guidewire will be probed gently to insert into the appendiceal lumen. The catheter will be then subsequently moved forward after the guidewire inserting deeply into the lumen under fluoroscopic guidance. Endoscopic retrograde appendicography (ERA): After cannulation of the appendiceal lumen, decompression of lumen will be achieved by suction using a 5-mL syringe attached to the catheter. A soluble contrast agent (iobitridol) will be then used to fill the appendix while being monitored by fluoroscopy to check the radiographic features of the appendix (including position, length, contour, mobility, intraluminal content and inner diameter of appendiceal lumen). Irrigation and appendicolith removal: The appendiceal lumen will be irrigated with normal saline solution to clear away the pus and the sand-like appendicoliths, while the large appendicoliths will be extracted using a balloon catheter or an extraction basket. Stenting for drainage: If the pus is massive or the lumen is stenosis, a plastic straight stent (8.5F) will be placed into the lumen over the guidewire for luminal decompression with the plan to retrieve the stent after about one week. 2) Antibiotic therapy group: The patients will be treated with intravenous broad-spectrum antibiotics (Carbapenems) for 3 days and oral antibiotics (Levofloxacin and Metronidazole) for 7 days. If patients in the antibiotic group deteriorate during the hospital stay (suspicious perforation or any symptoms of peritonitis) patients will be operated. 3) Appendectomy group: The patients will undergo laparoscopic appendectomy according to standard routines. Follow-up and outcome measures Follow-up will be performed until the end of the study period. The primary outcome is duration of abdominal pain. The secondary outcomes include mean hospital stay, mean operative time, duration of fever, duration of leukocytosis, bed time, rate of complication, rate of recurrence and rate of appendectomy during follow-up period of 1 year.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Appendicitis
Keywords
Acute appendicitis, Endoscopic retrograde appendicitis therapy, Endoscopic retrograde appendicography, Endoscopic therapy, Appendectomy, Antibiotic Therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
240 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Antibiotic therapy group
Arm Type
Active Comparator
Arm Description
The patients will be treated with intravenous broad-spectrum antibiotics (Ertapenem 1g/d) for 3 days and oral antibiotics (Levofloxacin 500mg once daily and Metronidazole 500mg 3 times per day) for 7 days. If patients in the antibiotic group deteriorate during the hospital stay (suspicious perforation or any symptoms of peritonitis) patients will be operated.
Arm Title
ERAT group
Arm Type
Experimental
Arm Description
The patients will receive emergent endoscopic retrograde appendicitis therapy (ERAT).
Arm Title
Appendectomy group
Arm Type
Active Comparator
Arm Description
The patients will receive laparoscopic appendectomy according to standard routines.
Intervention Type
Drug
Intervention Name(s)
Ertapenem, Levofloxacin and Metronidazole
Intervention Description
The patients will be treated with intravenous broad-spectrum antibiotics (Ertapenem 1g/d) for 3 days and oral antibiotics (Levofloxacin 500mg once daily and Metronidazole 500mg 3 times per day) for 7 days. If patients in the antibiotic group deteriorate during the hospital stay (suspicious perforation or any symptoms of peritonitis) patients will be operated.
Intervention Type
Procedure
Intervention Name(s)
Endoscopic retrograde appendicitis therapy (ERAT)
Intervention Description
The procedures of ERAT will be performed as below:1.Cannulation of the appendiceal lumen. 2.Endoscopic retrograde appendicography (ERA). 3.Irrigation and appendicolith removal. 4.Stenting for drainage.
Intervention Type
Procedure
Intervention Name(s)
Appendectomy
Intervention Description
The patients will receive laparoscopic appendectomy according to standard routines.
Primary Outcome Measure Information:
Title
duration of abdominal pain
Time Frame
up to 10 days
Secondary Outcome Measure Information:
Title
mean hospital stay
Time Frame
up to 10 days
Title
duration of fever
Time Frame
up to 10 days
Title
duration of leukocytosis
Time Frame
up to 10 days
Title
bed time
Time Frame
up to 10 days
Title
rate of complication
Time Frame
during follow-up period of 1 year
Title
rate of recurrence
Time Frame
during follow-up period of 1 year
Title
rate of appendectomy
Time Frame
during follow-up period of 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with Alvarado scores ≥7 (with or without US/CT) diagnosed of uncomplicated acute appendicitis patients with Alvarado scores <7 but US/CT suggested uncomplicated acute appendicitis or could not exclude acute appendicitis. Exclusion Criteria: perforated appendicitis periappendiceal abscess contraindications for colonoscopy allergy to contrast media or iodine pregnancy unable to cooperate or provide informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yingchao Li, MD,PhD
Phone
0086-18991232662
Email
lych123@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yingchao Li, MD,PhD
Organizational Affiliation
First Affiliated Hospital Xi'an Jiaotong University
Official's Role
Principal Investigator
Facility Information:
Facility Name
3201 Hospital of Hanzhong
City
Hanzhong
State/Province
Shaanxi
ZIP/Postal Code
723000
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhufang Ma, MD
Phone
0086-18292172137
Email
1304101066@qq.com
Facility Name
Second Affiliated Hospital of Xi'an Jiaotong University
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710004
Country
China
Facility Name
First Affiliated Hospital of Xian Jiaotong University
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710061
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yingchao Li, MD,PhD
Phone
0086-18991232662
Email
lych123@126.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
21550483
Citation
Vons C, Barry C, Maitre S, Pautrat K, Leconte M, Costaglioli B, Karoui M, Alves A, Dousset B, Valleur P, Falissard B, Franco D. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011 May 7;377(9777):1573-9. doi: 10.1016/S0140-6736(11)60410-8.
Results Reference
background
PubMed Identifier
26080338
Citation
Salminen P, Paajanen H, Rautio T, Nordstrom P, Aarnio M, Rantanen T, Tuominen R, Hurme S, Virtanen J, Mecklin JP, Sand J, Jartti A, Rinta-Kiikka I, Gronroos JM. Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis: The APPAC Randomized Clinical Trial. JAMA. 2015 Jun 16;313(23):2340-8. doi: 10.1001/jama.2015.6154.
Results Reference
background
PubMed Identifier
25106722
Citation
Liu BR, Ma X, Feng J, Yang Z, Qu B, Feng ZT, Ma SR, Yin JB, Sun R, Guo LL, Liu WG. Endoscopic retrograde appendicitis therapy (ERAT) : a multicenter retrospective study in China. Surg Endosc. 2015 Apr;29(4):905-9. doi: 10.1007/s00464-014-3750-0. Epub 2014 Aug 9.
Results Reference
background

Learn more about this trial

Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis

We'll reach out to this number within 24 hrs